Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast
Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of ...
Fierce Biotech1d
Daiichi taps Nosis to deliver RNA therapies beyond the liver
Daiichi Sankyo is stepping up its interest in RNA therapies, teaming with Nosis Biosciences to design drug candidates capable ...
Hub1d
Scientists design experimental protein booster for rare genetic diseases
Johns Hopkins scientists develop mRNA "booster" as potential new way to treat rare genetic diseases marked by too low levels ...
ChIP-mini technology advances analysis of DNA-protein interactions in pathogenic bacteria
In the pursuit of understanding the pathogenic expression mechanisms of bacteria and the advancements in biofoundry ...
PharmiWeb13d
Global Nucleic Acid Isolation and Purification Market Overview USD 2,038.1 Million by 2035 at a 5.6% of CAGR
The Nucleic Acid Isolation and Purification Market is projected to be valued at USD 1,178.6 million in 2025 and is expected to grow at a CAGR of 5.6% from 2025 to 2035, reaching USD 2,038.1 million by ...
AOL14d
Both lower and higher B12 levels may be linked to cognitive issues in older people
Vitamin B12, also known as cobalamin, is a water-soluble vitamin that is essential for developing and maintaining a healthy ...
The Herald Journal6d
Co-Diagnostics, Inc. Wins Dismissal of Class Action Lawsuit
Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform ...
Business Wire17d
Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio
Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics ... gene therapy, and RNA therapeutic development with cutting-edge ...